These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20880553)

  • 21. Is the Thoratec paracorporeal ventricular assist device a primary or secondary device to support patients with refractory cardiogenic shock?
    Aissaoui N; Diebold B; Fagon JY; Leprince P
    Arch Cardiovasc Dis; 2009; 102(6-7):473-5. PubMed ID: 19664566
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.
    Meyns B; Dens J; Sergeant P; Herijgers P; Daenen W; Flameng W
    Thorac Cardiovasc Surg; 2003 Dec; 51(6):312-7. PubMed ID: 14669126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock.
    Mandawat A; Rao SV
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28500136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulatory assistance in acute heart failure--where do we go from here?
    Hermansen SE; Naesheim T; How OJ; Myrmel T
    Scand Cardiovasc J; 2009 Aug; 43(4):211-6. PubMed ID: 19169932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal life support in cardiogenic shock: Impact of acute versus chronic etiology on outcome.
    Tarzia V; Bortolussi G; Bianco R; Buratto E; Bejko J; Carrozzini M; De Franceschi M; Gregori D; Fichera D; Zanella F; Bottio T; Gerosa G
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):333-40. PubMed ID: 25869084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-centre experience with the Thoratec paracorporeal ventricular assist device for patients with primary cardiac failure.
    Kirsch M; Vermes E; Damy T; Nakashima K; Sénéchal M; Boval B; Drouet L; Loisance D
    Arch Cardiovasc Dis; 2009; 102(6-7):509-18. PubMed ID: 19664570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival.
    Wu MY; Lin PJ; Lee MY; Tsai FC; Chu JJ; Chang YS; Haung YK; Liu KS
    Resuscitation; 2010 Sep; 81(9):1111-6. PubMed ID: 20627521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right Axillary Artery Conduit Is a Safe and Reliable Access for Implantation of Impella 5.0 Microaxial Pump.
    Boll G; Fischer A; Kapur NK; Salehi P
    Ann Vasc Surg; 2019 Jan; 54():54-59. PubMed ID: 30339902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.
    Engström AE; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; de Jong M; Lagrand WK; van der Sloot JA; Tijssen JG; de Winter RJ; de Mol BA; Piek JJ; Henriques JP
    Crit Care Med; 2011 Sep; 39(9):2072-9. PubMed ID: 21602670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the impella recover LP 5.0 as a bridge to surgery.
    La Torre MW; Centofanti P; Attisani M; Patanè F; Rinaldi M
    Tex Heart Inst J; 2011; 38(1):42-9. PubMed ID: 21423467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergency ventricular assist device: better survival rates in non-post cardiotomy-related cardiogenic shock.
    Rodrigus IE; Amsel BJ; Conraads V; De Hert S; Moulijn AC
    Acta Chir Belg; 2001; 101(5):226-31. PubMed ID: 11758106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful use of a percutaneous miniaturized extracorporeal life support system as a bridge and assistance to left ventricular assist device implantation in a patient with severe refractory cardiogenic shock.
    Haneya A; Philipp A; Puehler T; Camboni D; Hilker M; Hirt SW; Schmid C
    Perfusion; 2012 Jan; 27(1):18-20. PubMed ID: 21859786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction.
    Wiktor DM; Sawlani N; Kanthi Y; Sipahi I; Fang JC; Blitz A
    ASAIO J; 2010; 56(6):519-21. PubMed ID: 20938341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Use of Surgically Placed Impella 5.0 and Central Extracorporeal Membrane Oxygenation Circuit in a Patient with Postcardiotomy Shock.
    Abu Saleh WK; Mason P; Jabbari OA; Samir H; Bruckner BA
    Tex Heart Inst J; 2015 Dec; 42(6):569-71. PubMed ID: 26664314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of Impella 5.0 implantation using mini-sternotomy approach in postmyocardial infarction cardiogenic shock.
    Oses P; Casassus F; Leroux L; Calderon J; Barandon L
    J Card Surg; 2012 Sep; 27(5):605-6. PubMed ID: 22978837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.